Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients-A Prospective Study. Yahav D, Rahamimov R, Mashraki T, Ben-Dor N, et al. Transpl Int 2022;35:10204.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yahav D, Rahamimov R, Mashraki T, Ben-Dor N, et al. Immune Response to Third Dose BNT162b2 COVID-19 Vaccine Among Kidney Transplant Recipients-A Prospective Study. Transpl Int 2022;35:10204.
PMID: 35529596